| Summary of Net Revenue, Cost of Sales, Depreciation and Amortization, Operating Profit, and Interest Expense and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales, depreciation and amortization, operating profit, and interest expense for the three months ended February 28, 2025 and February 29, 2024:
|
|
|
|
|
|
|
|
|
|
|
For the three months ended |
|
|
|
February 28, 2025 |
|
|
February 29, 2024 |
|
Net revenue: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
7,865,888 |
|
|
$ |
7,805,522 |
|
PrepaCyte CB |
|
|
20,913 |
|
|
|
3,000 |
|
Public cord blood banking |
|
|
82,079 |
|
|
|
43,713 |
|
Total net revenue |
|
$ |
7,968,880 |
|
|
$ |
7,852,235 |
|
Cost of sales: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,701,635 |
|
|
$ |
1,790,469 |
|
PrepaCyte CB |
|
|
6,959 |
|
|
|
25,483 |
|
Public cord blood banking |
|
|
275,994 |
|
|
|
250,419 |
|
Total cost of sales |
|
$ |
1,984,588 |
|
|
$ |
2,066,371 |
|
Operating profit: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
1,242,917 |
|
|
$ |
1,057,719 |
|
PrepaCyte CB |
|
|
7,009 |
|
|
|
(29,428 |
) |
Public cord blood banking |
|
|
(193,915 |
) |
|
|
(207,068 |
) |
Total operating profit |
|
$ |
1,056,011 |
|
|
$ |
821,223 |
|
Depreciation and amortization: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
184,908 |
|
|
$ |
25,879 |
|
PrepaCyte CB |
|
|
6,945 |
|
|
|
6,945 |
|
Public cord blood banking |
|
|
— |
|
|
|
362 |
|
Total depreciation and amortization |
|
$ |
191,853 |
|
|
$ |
33,186 |
|
Interest expense: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service |
|
$ |
494,962 |
|
|
$ |
256,459 |
|
PrepaCyte CB |
|
|
— |
|
|
|
— |
|
Public cord blood banking |
|
|
— |
|
|
|
— |
|
Total interest expense |
|
$ |
494,962 |
|
|
$ |
256,459 |
|
The following table shows the assets by segment as of February 28, 2025 and November 30, 2024:
|
|
|
|
|
|
|
|
|
|
|
As of |
|
|
As of |
|
|
|
February 28, 2025 |
|
|
November 30, 2024 |
|
Assets: |
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell
service |
|
$ |
59,022,278 |
|
|
$ |
59,259,451 |
|
PrepaCyte CB |
|
|
117,466 |
|
|
|
138,169 |
|
Public cord blood banking |
|
|
5,241,323 |
|
|
|
5,280,013 |
|
Total assets |
|
$ |
64,381,067 |
|
|
$ |
64,677,633 |
|
|